Prostatis Group’s iShares ESG Optimized MSCI USA ETF SUSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,123
Closed -$351K 149
2024
Q2
$351K Buy
3,123
+117
+4% +$12.7K 0.12% 110
2024
Q1
$328K Buy
+3,006
New +$313K 0.12% 113
2023
Q4
Sell
-3,343
Closed -$301K 140
2023
Q3
$301K Sell
3,343
-87
-3% -$8.19K 0.15% 85
2023
Q2
$321K Buy
+3,430
New +$305K 0.15% 87
2023
Q1
Sell
-53,434
Closed -$4.4M 111
2022
Q4
$4.4M Buy
+53,434
New +$4.4M 2.68% 10
2022
Q2
Sell
-45,571
Closed -$4.41M 80
2022
Q1
$4.41M Sell
45,571
-42,723
-48% -$4.14M 3.54% 5
2021
Q4
$9.38M Buy
88,294
+11,080
+14% +$1.14M 5.75% 3
2021
Q3
$7.41M Buy
77,214
+12,715
+20% +$1.26M 4.43% 4
2021
Q2
$6.16M Buy
64,499
+21,298
+49% +$1.97M 4.21% 5
2021
Q1
$3.79M Buy
+43,201
New +$3.69M 2.98% 8

Other funds holding SUSA

Prostatis Group's SUSA Position: Q3 2024 in Review

Prostatis Group sold out of iShares ESG Optimized MSCI USA ETF (SUSA) in Q3 2024, closing a stake of 3,123 shares — an estimated $351K sold.

Prostatis Group first reported a position in SUSA in Q1 2021 and held it in 10 quarters. The position peaked at $9.38M in Q4 2021. 458 funds tracked by Wall St. Rank hold SUSA as of Q3 2024.

  • Prostatis Group reported no remaining iShares ESG Optimized MSCI USA ETF position as of Q3 2024 after selling out during the quarter.
  • Prostatis Group sold 3,123 iShares ESG Optimized MSCI USA ETF shares in Q3 2024, an estimated $351K.
  • Prostatis Group first reported a position in iShares ESG Optimized MSCI USA ETF in Q1 2021 and held it in 10 quarters.
  • Prostatis Group's iShares ESG Optimized MSCI USA ETF position peaked at $9.38M in Q4 2021.
  • 458 funds tracked by Wall St. Rank held iShares ESG Optimized MSCI USA ETF as of Q3 2024.

Based on Prostatis Group's 13F filing for Q3 2024, filed 21 Mar 2025.